Cancer Cell International accepted for indexing by Thomson Reuters

Cancer Cell International has recently been accepted for indexing by Thomson Reuters and is on course to receive its first impact factor in June this year. The journal, which is overseen by Editor-in-Chief Denys Wheatley, currently has an unofficial 2008 impact factor of 2.65. Cancer Cell International has also been accepted for inclusion in BIOSIS previews.

With this news, we are now expecting first impact factors for 18 of our journals this year and keenly anticipate the release of the Journal Citation Report in June.

Full details on indexing of all BioMed Central journals is available on our website.

View the latest posts on the BioMed Central blog homepage

Comments

By commenting, you’re agreeing to follow our community guidelines.

Your email address will not be published. Required fields are marked *